Bladder Cancer - Aug 20, 2017 Edition

Can't see this email? View it online

	August 20, 2017
	Bladder Cancer
	The latest bladder cancer news from News Medical

	Research offers explanation for ineffectiveness of checkpoint immunotherapy against bladder cancer New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

	Early life exposure to antibacterials could cause irreversible outcomes Lawrence Livermore National Laboratory scientists have discovered that exposure to environmental levels of triclocarban (TCC), an antibacterial chemical common in personal care products like soaps and lotions as well as in the medical field, can transfer from mother to offspring and interfere with lipid metabolism.

New research suggests cell immortalization as more complicated process than originally thought

A mutation that helps make cells immortal is critical to the development of a tumor, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally thought.

	Managing Neurogenic Bladder Neurogenic bladder control is a condition of loss of urinary function due to nerve, spinal cord or brain damage. A variety of circumstances can lead to neurogenic bladder, including spinal injury, neurologic disorders, or systemic disease of the body like diabetes.

	Diagnosing prostate cancer through a £225 urine test This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Update your Newsletter Subscriptions